Skip to main content
Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
281.00
+3.00 (1.08%)
Dec 5, 2025, 1:30 PM CST

Alar Pharmaceuticals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
18,7719,45211,9426,5552,6082,793
Upgrade
Market Cap Growth
84.87%-20.85%82.17%151.37%-6.63%-
Upgrade
Enterprise Value
16,4367,02811,3266,0462,0532,171
Upgrade
Last Close Price
281.00141.26208.00114.1845.4248.65
Upgrade
PE Ratio
-520.2131.21---
Upgrade
PS Ratio
14980.691624.9325.458193.75-4655.00
Upgrade
PB Ratio
7.753.7913.3112.744.884.67
Upgrade
P/TBV Ratio
7.753.7913.3112.744.884.67
Upgrade
P/FCF Ratio
--30.06---
Upgrade
P/OCF Ratio
--29.59---
Upgrade
EV/Sales Ratio
-1208.2224.147557.22-3617.60
Upgrade
EV/EBITDA Ratio
--29.22---
Upgrade
EV/EBIT Ratio
--29.38---
Upgrade
EV/FCF Ratio
-184.90-28.51---
Upgrade
Debt / Equity Ratio
0.0000.000.010.000.00
Upgrade
Debt / EBITDA Ratio
--0.00---
Upgrade
Debt / FCF Ratio
--0.00---
Upgrade
Asset Turnover
00.000.630.00-0.00
Upgrade
Quick Ratio
26.0644.1411.9890.70116.51135.92
Upgrade
Current Ratio
26.4944.3312.0892.66118.67143.31
Upgrade
Return on Equity (ROE)
-1.20%1.07%54.21%-3.79%-11.34%-36.17%
Upgrade
Return on Assets (ROA)
-3.24%-2.41%32.22%-5.47%-10.20%-26.68%
Upgrade
Return on Capital (ROIC)
-3.34%-2.50%34.04%-5.53%-10.27%-26.90%
Upgrade
Return on Capital Employed (ROCE)
-5.40%-2.70%42.90%-9.00%-17.40%-28.50%
Upgrade
Earnings Yield
-0.16%0.19%3.20%-0.30%-2.46%-5.11%
Upgrade
FCF Yield
-0.47%-0.74%3.33%-0.52%-2.49%-5.10%
Upgrade
Dividend Yield
0.09%0.18%0.72%---
Upgrade
Payout Ratio
-551.46%----
Upgrade
Buyback Yield / Dilution
-4.69%-16.08%-0.09%--14.21%-42.59%
Upgrade
Total Shareholder Return
-4.60%-15.90%0.63%--14.21%-42.59%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.